These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Monoclonal antibody therapy for malignant lymphoma]. Buske C; Dreyling M; Unterhalt M; Hiddemann W Med Klin (Munich); 2005 Jan; 100(1):14-24. PubMed ID: 15654538 [TBL] [Abstract][Full Text] [Related]
4. [Antibody therapy in hematology and oncology - part 1]. Kneba M; Schrader C; Köhne H Med Klin (Munich); 2008 Dec; 103(12):843-59. PubMed ID: 19099214 [No Abstract] [Full Text] [Related]
5. Focus on lymphomas. Staudt LM; Wilson WH Cancer Cell; 2002 Nov; 2(5):363-6. PubMed ID: 12450791 [No Abstract] [Full Text] [Related]
6. Rituximab plus short-duration chemotherapy followed by Yttrium-90 Ibritumomab tiuxetan as first-line treatment for patients with follicular non-Hodgkin lymphoma: a phase II trial of the Sarah Cannon Oncology Research Consortium. Hainsworth JD; Spigel DR; Markus TM; Shipley D; Thompson D; Rotman R; Dannaher C; Greco FA Clin Lymphoma Myeloma; 2009 Jun; 9(3):223-8. PubMed ID: 19525191 [TBL] [Abstract][Full Text] [Related]
7. [Proteins in haematology]. Clarenbach RE; Mey U Ther Umsch; 2011 Nov; 68(11):610-7. PubMed ID: 22045523 [TBL] [Abstract][Full Text] [Related]
8. Innovative strategies in lymphoma therapy. Jäger U Wien Klin Wochenschr; 2003 Aug; 115(13-14):462-70. PubMed ID: 13677264 [TBL] [Abstract][Full Text] [Related]
9. [Ten years since the successful introduction of the first monoclonal antibody (rituximab) into the therapy of lymphomas]. Trnený M; Klener P Cas Lek Cesk; 2007; 146(7):578-85. PubMed ID: 17722844 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies in the treatment of cancer, Part 1. Cersosimo RJ Am J Health Syst Pharm; 2003 Aug; 60(15):1531-48. PubMed ID: 12951753 [TBL] [Abstract][Full Text] [Related]